Alkido Pharma Inc (AIKI) |
|
0.5823 0.002 (0.38%)
|
10-23 23:49 |
|
Open: |
0.5782 |
Pre. Close: |
0.5801 |
|
High:
|
0.5885 |
Low:
|
0.57 |
|
Volume:
|
309,578 |
Market Cap:
|
20M |
|
|
|
|
Aikido Pharma Inc., formerly Spherix Incorporated, is a biotechnology company. The Company is focused on developing a diverse portfolio of small-molecule anti-cancer therapeutics. Its diverse pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). In addition, the Company is constantly seeking to grow its pipeline to treat its unmet medical needs in oncology. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
0.59 - 0.593 |
0.593 - 0.596 |
|
Low:
|
0.563 - 0.566 |
0.566 - 0.569 |
|
Close:
|
0.575 - 0.58 |
0.58 - 0.584 |
|
Technical analysis |
as of: 2020-10-23 4:40:23 PM |
|
Overall:
|
  |
| Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected. |
| Target: |
Six months: 0.72 One year: 0.81 |
| Support: |
Support1: 0.50 Support2: 0.42 |
| Resistance: |
Resistance1: 0.62 Resistance2: 0.69 |
| Pivot: |
0.59  |
| Moving Average: |
MA(5): 0.58 MA(20): 0.59
MA(100): 0.78 MA(250): 0.93 |
| MACD: |
MACD(12,26): -0.02 Signal(9): -0.02 |
| Stochastic oscillator: |
%K(14,3): 26.74 %D(3): 24.79 |
| RSI: |
RSI(14): 45.00 |
| 52-week: |
High: 5.52 Low: 0.48 Change(%): -52.7 |
| Average Vol(K): |
3-Month: 185426 10-Days: 53791 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.AIKI has closed above bottom band by 36.8%. Bollinger Bands are 70% narrower than normal. The narrow width of the bands suggests low volatility as compared to AIKI's normal range. The bands have been in this narrow range for 26 bars. This is a sign that the market may be about to initiate a new trend. |
|
|
Headline News |
Wed, 30 Sep 2020
Alkido Pharma Inc. (NASDAQ:AIKI) Announce Updates From Cogia BioTech Efforts To Use AI In Targeted PDA Treatment - BP Journal
Fri, 26 Jun 2020
AIkido Pharma Inc. Provides Update to Machine Learning Pancreatic Cancer Research - PRNewswire
Thu, 28 May 2020
AIkido Pharma Announces Publication of Results from Sponsored Research at Wake Forest University - PRNewswire
Tue, 19 May 2020
AIkido Pharma Inc. Announces Distribution of Hoth Dividend - Yahoo Finance
Tue, 12 May 2020
What You Must Know About AIkido Pharma Inc.'s (NASDAQ:AIKI) Beta Value - Yahoo Finance UK
Wed, 15 Apr 2020
AIkido Pharma Inc. Announces Closing of $14.0 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules - PRNewswire
|
Financial Analysis |
| Growth |
n/a |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
n/a |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
n/a |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
n/a |
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Price to Book Value: |
Outperform |
Discounted cash flow: |
Outperform |
| Return on Assets: |
Neutral |
Price to Earnings: |
Underperform |
| Return on Equity: |
Neutral |
Debt to Equity: |
Neutral |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NASDAQ |
| Sector: Healthcare |
| Industry: Biotechnology |
| Shares Out. (M) |
35 |
| Shares Float (M) |
29 |
|
% Held by Insiders
|
5.64 |
|
% Held by Institutions
|
17.45 |
|
Shares Short (K)
|
1,760 |
|
Shares Short P. Month (K)
|
56 |
Stock Financials |
|
EPS
|
|
|
EPS Est This Year
|
|
|
EPS Est Next Year
|
|
|
Book Value (p.s.)
|
|
|
Profit Margin
|
|
|
Operating Margin
|
-91966.66 |
|
Return on Assets (ttm)
|
-23.2 |
|
Return on Equity (ttm)
|
-61.1 |
|
Qtrly Rev. Growth
|
|
|
Gross Profit (p.s.)
|
|
|
Sales Per Share
|
|
|
EBITDA (p.s.)
|
|
|
Qtrly Earnings Growth
|
|
|
Operating Cash Flow (M)
|
-4 |
|
Levered Free Cash Flow (M)
|
-6 |
Stock Valuations |
|
PE Ratio
|
|
|
PEG Ratio
|
|
|
Price to Book value
|
|
|
Price to Sales
|
2259.32 |
|
Price to Cash Flow
|
-5.37 |
Stock Dividends |
|
Dividend
|
|
|
Forward Dividend
|
|
|
Dividend Yield
|
|
|
Dividend Pay Date
|
Invalid DateTime. |
|
Ex-Dividend Date
|
1980-05-11 |
|
7 Binary Options
|
|
Your Ad Here
|
|
